Pfizer advances clinical trials for 5- to 11-year-olds at lower doses
carmengabriela/iStock (NEW YORK) -- Pfizer is advancing Phase 2/3 clinical trials for young kids at lower doses than vaccines for adults, the pharmaceutical company announced Tuesd…
